VRK1 Promotes Cisplatin Resistance by Up-Regulating C-Myc via C-Jun Activation and Serves as a Therapeutic Target in Esophageal Squamous Cell Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.20020
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC